| Dermatitis, Atopic
Eucrisa vs Ebglyss
Side-by-side clinical, coverage, and cost comparison for dermatitis, atopic.Deep comparison between: Eucrisa vs Ebglyss with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsEbglyss has a higher rate of injection site reactions vs Eucrisa based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Ebglyss but not Eucrisa, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Eucrisa
Ebglyss
At A Glance
Topical
Twice daily
PDE-4 inhibitor
SC injection
Every 2-4 weeks
IL-13 antagonist
Indications
- Dermatitis, Atopic
- Dermatitis, Atopic
Dosing
Dermatitis, Atopic Apply a thin layer twice daily to affected areas; once clinical effect is achieved, consider reducing to once daily. For topical use only.
Dermatitis, Atopic 500 mg (two 250 mg injections) SC at Week 0 and Week 2, then 250 mg every 2 weeks until Week 16 or adequate clinical response; maintenance dose is 250 mg every 4 weeks SC.
Contraindications
- Known hypersensitivity to crisaborole or any component of the formulation
- Prior serious hypersensitivity to lebrikizumab-lbkz or any excipient of EBGLYSS
Adverse Reactions
Most common (>=1%) Application site pain
Postmarketing Allergic contact dermatitis
Most common (>=1%) conjunctivitis, injection site reactions, herpes zoster
Serious hypersensitivity, conjunctivitis, keratitis
Pharmacology
Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor; PDE-4 inhibition results in increased intracellular cyclic adenosine monophosphate (cAMP) levels, though the specific mechanism by which it treats atopic dermatitis is not well defined.
Lebrikizumab-lbkz is an IgG4 monoclonal antibody that binds with high affinity to IL-13, inhibiting IL-13 signaling through the IL-4Ra/IL-13Ra1 receptor complex; IL-13 is a cytokine central to Type 2 inflammation in atopic dermatitis pathogenesis.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Eucrisa
- Covered on 5 commercial plans
- PA (9/12) · Step Therapy (10/12) · Qty limit (9/12)
Ebglyss
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (10/12) · Qty limit (9/12)
UnitedHealthcare
Eucrisa
- Covered on 4 commercial plans
- PA (1/8) · Step Therapy (4/8) · Qty limit (5/8)
Ebglyss
- Covered on 4 commercial plans
- PA (8/8) · Step Therapy (8/8) · Qty limit (4/8)
Humana
Eucrisa
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (3/3) · Qty limit (3/3)
Ebglyss
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (3/3) · Qty limit (3/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Eucrisa.
$25/momo
Ebglyss Savings Card - Non-covered benefitCommercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
EucrisaView full Eucrisa profile
EbglyssView full Ebglyss profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.